Powerful Medical
7. September 2023

Summary: PMcardio at ESC Congress 2023

We’re buzzing with excitement following our exhilarating experience at this year’s ESC Congress in Amsterdam. At the biggest cardiology event of the year, the PMcardio booth served as a hub for transformative conversations, attracting some of the most eminent minds in cardiology. Here’s a recap of the major developments.

The OMI Paradigm Shift

Our activities at the global event highlighted the significance of the OMI/NOMI paradigm shift in the management of acute heart attacks. Led by Prof. Dr. Steve Smith and Dr. Pendell Meyers, this approach aims to rectify the diagnostic gaps left by the traditional STEMI/NSTEMI model. Although this model has been instrumental in the past, it frequently overlooks patients requiring immediate intervention for acute coronary occlusion. The OMI paradigm, although eye-opening, necessitates high-level ECG interpretation skills, making its widespread adoption a challenge.

Introducing Queen of Hearts: The OMI Game-Changer

This leads us to PMcardio’s groundbreaking Queen of Hearts OMI AI algorithm. Engineered to meet the challenges of the OMI paradigm, it detects OMI cases with twice the sensitivity and three hours ahead of current methods. This revolutionary AI model enables any practitioner to detect Oclusion Myocardial Infarction, in both STEMI and NSTEMI patients, allowing for prompt intervention. The integration of such technology into the hospital and emergency workstreams allows prompt intervention for Acute Coronary Syndrome patients, not only saving their life but also preventing post-ACS complications and minimising the chances of the patients developing dangerous conditions, such as Heart Failure.

OMI AI Model in Clinical Practice

We’re excited to announce that the groundbreaking Queen of Hearts algorithm is set to be integrated into PMcardio’s app and API solutions. Scheduled for release in October 2023, this advanced OMI AI model is currently in clinical trials at more than 60 centers worldwide. With thousands of medical professionals already on our waiting list, The Queen of Hearts is already resonating strongly within the medical community.

Powerful Medical Research Presented at ESC Congress 2023:

  • “Validation of Artificial Intelligence Model for 12-lead ECG Interpretation”Dr. Anthony Demolder
  • “Diagnostic accuracy of a smartphone application for artificial intelligence-based interpretation of 12-lead ECG in primary care” Dr. Jelle Himmelreich
  • “ECG-based Deep Learning for Detecting Epicardial Occlusion in Acute Myocardial Infarction”Dr. Robert Herman
  • “Poor Prognosis of Total Culprit Artery Occlusion in Patients Presenting with NSTEMI”Dr. Robert Herman

About the Queen of Hearts:

PMcardio’s OMI AI Model, also known as the Queen of Hearts, enables physicians to detect Occlusion Myocardial Infarction (OMI) from any 12-lead ECG in STEMI and NSTEMI patients. Although this criterium has been instrumental in the past, it frequently overlooks patients requiring immediate intervention for Acute Coronary Occlusion. The Queen of Hearts has been developed to rectify the diagnostic gaps left by the traditional STEMI/NSTEMI model, targeting frequent misidentification and delayed management of acute Acute Coronary Syndrome (ACS).

Using current diagnostic methods, nearly 30% of Myocardial Infarction (MI) cases categorised as NSTEMI are in fact false negatives. The integration of the OMI AI Model into hospital and emergency care workstreams enables effective patient triage, facilitating immediate interventions for genuine OMI cases. This minimises the risk of post-ACS complications and reduces the chance of patients developing chronic conditions such as Heart Failure. Conversely, approximately 15% of cases identified as STEMI prove to be false positives. These instances lead to unnecessary surgical procedures, consuming cath lab resources that could be more appropriately allocated to patients in acute need.

With double the sensitivity and three hours ahead of the current standard of care, the Queen of Hearts emerges as the new golden standard in diagnostic precision. It equips healthcare professionals with an invaluable tool for informed decision-making, enabling timely and appropriate care. This state-of-the-art technology not only extends but also enhances the lives of patients with cardiovascular conditions.

About ESC Congress: 

The ESC Congress 2023, organized by the European Society of Cardiology (ESC), is the world’s largest conference in cardiovascular medicine. It will be held from August 25 to August 28, 2023, in Amsterdam, Netherlands. The theme of the congress is “Joining forces to protect the heart”. The spotlight of ESC Congress 2023 will be heart failure, which is relevant to all areas of cardiology and beyond. The congress aims to provide the latest research findings, in-depth science, and clinical teaching in cardiovascular medicine.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Dr. Schmelzer’s Turning Point: How a Severe Chest Pain Case Inspired PMcardio Adoption

The case of a 76-year-old patient with severe chest pain prompted Dr. Schmelzer to delve into the nuances of Occlusive Myocardial Infarction (OMI) versus the conventional STEMI/NSTEMI classification. His research led him to discover the PMcardio OMI AI model.
Left Ventricular Systolic Dysfunction (LVSD) (2)

Left Ventricular Systolic Dysfunction: The Basics and Advancements in Detection

In this comprehensive article, we delve into the intricacies of Left Ventricular Systolic Dysfunction (LVSD), thoroughly analyzing its symptoms, causes, and severity. We explore the latest advancements in diagnostic tools and real-world case studies.

Join 25,000 healthcare professionals who are already taking advantage of AI